Get Free Delivery With No Minimum Order

FENSOLIN 10/MG FC TAB 30/FC TAB
- Sku : I-026122
Key features
FENSOLIN 10 mg Film-coated tablet contains solifenacin succinate 10 mg, an antimuscarinic urinary medicine in film-coated tablet form. It works by selectively blocking M3 muscarinic receptors in the bladder to reduce involuntary contractions and increase bladder capacity. It is used for the treatment of overactive bladder, including symptoms of urge urinary incontinence, urgency, and urinary frequency. This product is supplied as a pack of 30 film-coated tablets.- Brand: FENSOLIN
- Active Ingredient: SOLIFENACIN SUCCINATE 10mg
- Strength: 10mg
- Dosage Form: Film-coated tablet
- Pack Size: 30 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Urological
- Pharmacological Group: Urologicals (BPH & Bladder)
- Drug Class: Antimuscarinic (anticholinergic) urinary antispasmodic; relatively M3‑selective muscarinic receptor antagonist.
- Manufacturer: Jamjoom Pharmaceuticals Factory Company
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1610234338
- Shelf Life: 36 months
- Storage: store below 30°c
- Urological Condition: Overactive Bladder
Indications
Approved Uses
Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Dosage & Administration
Dosing by Condition
Overactive bladder (OAB): 5 mg orally once daily initially; may increase to 10 mg once daily based on response and tolerability; maximum 10 mg once daily.
Maximum Dose
10 mg once daily.
How to Take
Swallow the film‑coated tablet whole with water; do not crush or chew. May be taken with or without food, preferably at the same time each day.
Side Effects
Common Side Effects
Dry mouth, constipation, nausea, dyspepsia, blurred vision, dry eyes, urinary tract infection, fatigue
Drug Interactions
Food Interaction
No restriction - can be taken with or without food
Pharmacology
Mechanism of Action
Competitive muscarinic receptor antagonist with relative selectivity for M3 receptors in the bladder detrusor, reducing acetylcholine‑mediated contractions and increasing bladder capacity.
Half-Life
45-68 hours
Product Information
Urological Condition
Overactive Bladder
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)



